PATENT CLAIM ANALYSIS

Application Number: 15984919
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "070000"]

Abstract:
The invention relates to 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives, their preparation and their use in medicine, particularly in the treatment of pain.

Claim (Index 11):
The compound according to  claim 1 , wherein R 4  means \u2014C 1 -C 6 -alkyl, linear or branched, saturated or unsaturated, unsubstituted, mono- or polysubstituted.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.17857
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12699451', '11994001', '12700857', '12604691', '15125615']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.83797698989869
- 35 USC 102 Novelty (BERT): 0.5353163382350888
- Combined Prediction Score: 0.8077109247323299
- Mean Citation Score: 379.6739940000001
- Max Citation Score: 389.5721
- Similarity Product: 253.0527886592686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test